Alice Soragni of the UCLA Jonsson Comprehensive Cancer Center has received a $2.5 million grant from the NCI to develop lab-grown mini tumors that can help identify treatments for rare types of neuroendocrine cancer.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe